METHODS OF TREATING CANCER USING ANTAGONISTS BINDING TO COMPONENTS OF THE SIGNAL PATH PD-1, AND TAXANES Russian patent published in 2020 - IPC A61K31/337 A61K39/395 A61P35/00 

Abstract RU 2719487 C2

FIELD: medicine.

SUBSTANCE: group of inventions relates to a method of treating or slowing the progression of non-squamous non-small cell lung cancer (NSCLC) in an individual, comprising administering to an individual an effective amount of an antagonist binding to a component of the PD-1 signaling pathway, taxane and a platinum-based chemotherapeutic agent, wherein the taxane is nab-paclitaxel or paclitaxel. Group of inventions also relates to a method of enhancing immune function in an individual with non-squamous NSCLC, comprising administering an antagonist which binds to a component of a PD-1 signaling pathway, taxane and a platinum-based chemotherapeutic agent; combinations for treating or slowing the progression of non-flat-cell NSCLC in an individual; kit for treating or delaying the progression of non-squamous NSCLC in an individual.

EFFECT: group of inventions provides a strong antitumour effect, including a high frequency of "complete remission", id est no detectable tumor mass.

95 cl, 2 ex, 6 dwg, 5 tbl

Similar patents RU2719487C2

Title Year Author Number
COMPOSITIONS FOR TREATING CANCER USING ANTAGONISTS WHICH BIND TO THE PD-1 SIGNALING PATHWAY COMPONENT AND MEK INHIBITORS 2015
  • Junttila, Melissa
RU2733735C2
ANTI-TIGIT ANTIBODIES AND METHODS OF USING 2016
  • Grogan, Jane, L.
  • Johnston, Robert, J.
  • Wu, Yan
  • Liang, Wei-Ching
  • Lupardus, Patrick
  • Yadav, Mahesh
  • Seshasayee, Dhaya
  • Hazen, Meredith
RU2732591C2
ANTI-TIGIT ANTIBODIES AND METHODS OF USE 2016
  • Grogan, Dzhejn, L.
  • Dzhonston, Robert, Dzh.
  • Vu, Yan
  • Lyang, Vej-Ching
  • Lupardus, Patrik
  • Yadav, Manesh
  • Seshasajee, Dkhaja
  • Khejzen, Meredit
RU2817838C2
FGFR2 INHIBITORS SEPARATELY OR IN COMBINATION WITH IMMUNOSTIMULATING AGENTS IN CANCER TREATMENT 2016
  • Pierce, Kristen
  • Powers, Janine
  • Palencia, Servando
  • Sikorski, Robert
  • Ghoddusi, Majid
  • Krishnan, Kartik
RU2745707C2
ANTI-PD-L1 ANTIBODIES AND METHODS FOR THEIR DIAGNOSTIC USE 2015
  • Liao Zhiming
  • Kowanetz Marcin
  • Boyd Zachary
  • Koeppen Hartmut
  • Roche Patrick C.
  • Zhu Yifei
  • Vennapusa Bharathi
RU2715038C2
HUMANIZED ANTIBODIES AND ANTIBODIES WITH MATURE AFFINITY AGAINST FcRH5 AND METHODS FOR THEIR APPLICATION 2016
  • Hotzel, Isidro
  • Junttila, Teemu, T.
  • Li, Ji
  • Scheer, Justin
  • Dicara, Danielle
  • Ellerman, Diego
  • Spiess, Christoph
  • Carter, Paul
RU2748943C2
BISPECIFIC ANTIGEN-BINDING MOLECULES AND METHODS OF THEIR USE 2019
  • Ellerman, Diego
  • Dzhunttila, Timu, T.
  • Lombana, Tvila, Noell
  • Slaga, Dionisos
  • Spiss, Kristof
RU2800779C2
METHODS FOR TREATING CANCER, INCLUDING TIGIT-BINDING AGENTS 2017
  • Dyupon, Dzhejkob
  • Parmar, Khema
RU2765410C2
TARGETED TGF BETA INHIBITION 2015
  • Lo Kin-Min
RU2752424C2
ANTIBODY-DRUG CONJUGATES AND METHODS OF USING SAID CONJUGATES OF PYRROLOBENZODIAZEPINE 2016
  • Dragovich Peter
  • Pillow Thomas
  • Sadowsky Jack
  • Sliwkowski Mark X.
  • Wei Binqing
RU2736725C1

RU 2 719 487 C2

Authors

Kim Jeong

Cheung Jeanne

Dates

2020-04-17Published

2014-12-17Filed